⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8089108 | 0.86 | PSMB11 (0.45) | — | |
| SCHEMBL270119 | 0.85 | HDAC6 (0.39) | — | |
| SCHEMBL5791476 | 0.85 | PSMB11 (0.51) | — | |
| SCHEMBL5791472 | 0.85 | PSMB11 (0.51) | — | |
| SCHEMBL8089119 | 0.83 | PSMB11 (0.54) | — | |
| SCHEMBL5794870 | 0.83 | PSMB11 (0.54) | — | |
| SCHEMBL31306995 | 0.83 | PSMB11 (0.54) | — | |
| SCHEMBL5794871 | 0.83 | PSMB11 (0.54) | — | |
| SCHEMBL22294215 | 0.81 | — | — | |
| SCHEMBL5409558 | 0.81 | TAS1R3 (0.57) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0758361-B1 | POLYMERISABLE COMPOSITION AND THE USE THEREOF | NOVARTIS AG (CH) | 2000-11-15 | — | — | EP | disclosed |
| US-5852126-A | Polymerisable composition and the use thereof | NOVARTIS AG (CH) | 1998-12-22 | — | — | US | disclosed |
| EP-0758361-A1 | POLYMERISABLE COMPOSITON AND THE USE THEREOF | Novartis AG (CH) | 1997-02-19 | — | — | EP | disclosed |
| WO-1995029959-A1 | POLYMERISABLE COMPOSITON AND THE USE THEREOF | CIBA-GEIGY AG (CH) | 1995-11-09 | — | — | WO | disclosed |